CVS Health (CVS) vs 111 (YI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
CVS Health (CVS) has outperformed 111 (YI) over the past year, gaining 14.0% versus a loss of 33.1%. Over five years, CVS leads with a +2.5% price change compared with -44.2% for YI. CVS Health is the larger company by market cap ($112.49 billion vs $27.7 million), about 4059.3 times the size.
On valuation, CVS Health trades at a lower forward P/E (10.3x vs 22.5x for 111). CVS Health pays a dividend yielding 3.02%, while 111 does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CVS | YI |
|---|---|---|
| Share price | $87.95 | $3.15 |
| Market cap | $112.49B | $27.71M |
| 1-day change | +1.76% | +1.94% |
| YTD return | +10.82% | +23.05% |
| 1-year return | +14.04% | -33.12% |
| 5-year return | +2.46% | -44.25% |
| P/E ratio (TTM) | 23.14 | 0.31 |
| Forward P/E | 10.30 | 22.50 |
| EPS (TTM) | $3.80 | $10.26 |
| Dividend yield | 3.02% | 0.00% |
| Annual dividend | $2.66 | $0.00 |
| Revenue (latest FY) | $402.07B | — |
| Revenue growth (YoY) | +7.85% | — |
| Net income (latest FY) | $1.77B | — |
| Gross margin | 44.99% | — |
| Operating margin | 1.16% | — |
| Net margin | 0.44% | — |
| 52-week high | $110.68 | $11.17 |
| 52-week low | $69.51 | $2.48 |
| Distance from 52-week high | -20.54% | -71.80% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +31.62% | — |
| Average volume | 7.96M | 11.33K |
| Shares outstanding | 1.28B | 5.20M |
| Employees | 219,000 | — |
| Sector | Consumer Staples | Consumer Staples |
| Industry | Retail-Drug Stores and Proprietary Stores | Retail-Drug Stores and Proprietary Stores |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CVS Health is about 4059.3 times larger than 111 by market value ($112.49B vs $27.71M).
- CVS has outperformed YI by 47.2 percentage points over the past year.
- CVS Health trades at a higher earnings multiple (23.1x vs 0.3x trailing P/E).
- CVS Health offers a meaningfully higher dividend yield (3.02% vs 0.00%).
About CVS Health
CVS stock →CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services.
Consumer Staples · Retail-Drug Stores and Proprietary Stores · 219,000 employees
CVS vs YI FAQ
Which is bigger, CVS Health or 111?
CVS Health (CVS) is larger, with a market capitalization of $112.49B compared with $27.71M for 111 (YI).
Which stock has performed better over the past year, CVS or YI?
CVS returned +14.04% over the past 12 months, compared with -33.12% for YI (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, CVS or YI?
YI has the lower trailing P/E at 0.3, versus 23.1 for CVS. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, CVS Health or 111?
CVS Health pays a dividend yielding 3.02%, while 111 does not currently pay a regular dividend.
Are CVS Health and 111 in the same industry?
Yes. Both are classified in the Retail-Drug Stores and Proprietary Stores industry within the Consumer Staples sector.